JP2015508828A5 - - Google Patents

Download PDF

Info

Publication number
JP2015508828A5
JP2015508828A5 JP2014560091A JP2014560091A JP2015508828A5 JP 2015508828 A5 JP2015508828 A5 JP 2015508828A5 JP 2014560091 A JP2014560091 A JP 2014560091A JP 2014560091 A JP2014560091 A JP 2014560091A JP 2015508828 A5 JP2015508828 A5 JP 2015508828A5
Authority
JP
Japan
Prior art keywords
amino
pyridin
pyrimidin
optionally substituted
fluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014560091A
Other languages
English (en)
Japanese (ja)
Other versions
JP6068515B2 (ja
JP2015508828A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/028622 external-priority patent/WO2013130976A1/en
Publication of JP2015508828A publication Critical patent/JP2015508828A/ja
Publication of JP2015508828A5 publication Critical patent/JP2015508828A5/ja
Application granted granted Critical
Publication of JP6068515B2 publication Critical patent/JP6068515B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014560091A 2012-03-01 2013-03-01 セリン/トレオニンキナーゼ阻害剤 Active JP6068515B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261605523P 2012-03-01 2012-03-01
US61/605,523 2012-03-01
PCT/US2013/028622 WO2013130976A1 (en) 2012-03-01 2013-03-01 Serine/threonine kinase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015179810A Division JP2016027053A (ja) 2012-03-01 2015-09-11 セリン/トレオニンキナーゼ阻害剤

Publications (3)

Publication Number Publication Date
JP2015508828A JP2015508828A (ja) 2015-03-23
JP2015508828A5 true JP2015508828A5 (enExample) 2015-11-05
JP6068515B2 JP6068515B2 (ja) 2017-01-25

Family

ID=47892024

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014560091A Active JP6068515B2 (ja) 2012-03-01 2013-03-01 セリン/トレオニンキナーゼ阻害剤
JP2015179810A Withdrawn JP2016027053A (ja) 2012-03-01 2015-09-11 セリン/トレオニンキナーゼ阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015179810A Withdrawn JP2016027053A (ja) 2012-03-01 2015-09-11 セリン/トレオニンキナーゼ阻害剤

Country Status (36)

Country Link
US (4) US8697715B2 (enExample)
EP (2) EP2820009B1 (enExample)
JP (2) JP6068515B2 (enExample)
KR (1) KR102093526B1 (enExample)
CN (2) CN106349217B (enExample)
AR (2) AR090220A1 (enExample)
AU (1) AU2013225737B2 (enExample)
BR (1) BR112014021634B1 (enExample)
CA (1) CA2866086C (enExample)
CL (1) CL2014002301A1 (enExample)
CO (1) CO7081155A2 (enExample)
CR (1) CR20140413A (enExample)
CY (1) CY1120172T1 (enExample)
DK (2) DK2820009T3 (enExample)
ES (2) ES2857649T3 (enExample)
HR (2) HRP20180591T1 (enExample)
HU (2) HUE053994T2 (enExample)
IL (2) IL234376A (enExample)
LT (2) LT3321262T (enExample)
MX (1) MX354675B (enExample)
MY (1) MY191936A (enExample)
NO (1) NO2945854T3 (enExample)
NZ (1) NZ700314A (enExample)
PE (1) PE20150666A1 (enExample)
PH (3) PH12014501947B1 (enExample)
PL (2) PL2820009T3 (enExample)
PT (2) PT2820009T (enExample)
RS (2) RS57097B1 (enExample)
RU (1) RU2650501C2 (enExample)
SG (1) SG11201405356QA (enExample)
SI (2) SI3321262T1 (enExample)
SM (1) SMT201800282T1 (enExample)
TW (1) TWI589569B (enExample)
UA (1) UA116774C2 (enExample)
WO (1) WO2013130976A1 (enExample)
ZA (2) ZA201406688B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2543050T3 (es) 2011-02-28 2015-08-14 Array Biopharma, Inc. Inhibidores de serina/treonina quinasa
EP2739618B1 (en) 2011-08-04 2015-09-16 Array Biopharma, Inc. Quinazoline compounds as serine/threonine kinase inhibitors
AR090220A1 (es) * 2012-03-01 2014-10-29 Array Biopharma Inc Inhibidores de serina/treonina cinasa
JP6218808B2 (ja) * 2012-05-03 2017-10-25 ジェネンテック, インコーポレイテッド Lrrk2モジュレ−タ−としてのピラゾ−ルアミノピリミジン誘導体
MX369989B (es) 2012-08-27 2019-11-27 Array Biopharma Inc Inhibidores de serina/treonina cinasa para el tratamiento de enfermedades hiperproliferativas.
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
JP2015533151A (ja) 2012-10-16 2015-11-19 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト セリン/スレオニンキナーゼ阻害剤
WO2017156493A1 (en) 2016-03-11 2017-09-14 Denali Therapeutics Inc. Compounds, compositions, and methods
US9532987B2 (en) 2013-09-05 2017-01-03 Genentech, Inc. Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases
ES2684360T3 (es) 2013-11-01 2018-10-02 Novartis Ag Aminoheteroaril benzamidas como inhibidores de quinasa
US9867833B2 (en) 2013-12-06 2018-01-16 Genentech, Inc. Serine/threonine kinase inhibitors
WO2015103137A1 (en) 2013-12-30 2015-07-09 Array Biopharma Inc. Serine/threonine kinase inhibitors
CA2934679C (en) * 2013-12-30 2023-02-28 Genentech, Inc. Serine/threonine kinase inhibitors
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
JP6723926B2 (ja) * 2014-04-09 2020-07-15 ジェネンテック, インコーポレイテッド 医薬の製造方法
US9879029B2 (en) 2014-12-22 2018-01-30 Eli Lilly And Company ERK inhibitors
TWI704151B (zh) 2014-12-22 2020-09-11 美商美國禮來大藥廠 Erk抑制劑
US10238657B2 (en) * 2015-06-03 2019-03-26 Js Innopharm (Shanhai) Ltd. Heterocyclic compounds for treating psoriasis
US10479791B2 (en) * 2015-06-03 2019-11-19 Changzhou Jiekai Pharmatech Co. Ltd Heterocyclic compounds as ERK inhibitors
US10457669B2 (en) 2015-10-21 2019-10-29 Otsuka Pharmaceutical Co., Ltd. Benzolactam compounds as protein kinase inhibitors
US10208024B2 (en) 2015-10-23 2019-02-19 Array Biopharma Inc. 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
WO2017080979A1 (en) 2015-11-09 2017-05-18 Astrazeneca Ab Dihydroimidazopyrazinone derivatives useful in the treatment of cancer
US11214565B2 (en) 2015-11-20 2022-01-04 Denali Therapeutics Inc. Compound, compositions, and methods
KR20180134347A (ko) 2016-04-15 2018-12-18 제넨테크, 인크. 암의 진단 및 치료 방법
PT3472153T (pt) 2016-06-16 2021-12-31 Denali Therapeutics Inc Pirimidin-2-ilamino-1h-pirazóis como inibidores de lrrk2 para uso no tratamento de distúrbios neurodegenerativos
GB201706327D0 (en) 2017-04-20 2017-06-07 Otsuka Pharma Co Ltd A pharmaceutical compound
WO2019037640A1 (en) * 2017-08-22 2019-02-28 Js Innopharm (Shanghai) Ltd HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS COMPRISING THE HETEROCYCLIC COMPOUND, AND METHODS OF USING THE SAME
TWI787335B (zh) * 2017-08-23 2022-12-21 瑞典商斯普林特生物科技公司 吡啶基吡啶酮化合物
US11859252B2 (en) 2017-09-08 2024-01-02 Genentech, Inc. Diagnostic and therapeutic methods for cancer
JP7091455B2 (ja) 2017-11-24 2022-06-27 ノバルティス アーゲー ピリジノン誘導体及びそれらの選択的alk-2阻害剤としての使用
WO2019154364A1 (zh) * 2018-02-08 2019-08-15 南京明德新药研发有限公司 作为fgfr抑制剂的吡嗪-2(1h)-酮类化合物
EP3752200A1 (en) 2018-02-13 2020-12-23 Vib Vzw Targeting minimal residual disease in cancer with rxr antagonists
EP3797109A4 (en) * 2018-05-22 2022-02-23 JS Innomed Holdings Ltd. HETEROCYCLIC COMPOUNDS USED AS KINASE INHIBITORS, COMPOSITIONS COMPRISING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF
EP3898615A1 (en) 2018-12-19 2021-10-27 Array Biopharma, Inc. 7-((3,5-dimethoxyphenyl)amino)quinoxaline derivatives as fgfr inhibitors for treating cancer
CN113490666A (zh) 2018-12-19 2021-10-08 奥瑞生物药品公司 作为fgfr酪氨酸激酶的抑制剂的取代的吡唑并[1,5-a]吡啶化合物
JP2022527744A (ja) * 2019-03-28 2022-06-06 ジエンス ヘンルイ メデイシンカンパニー リミテッド チエノ複素環式誘導体、この誘導体のための調製方法及び医療に関するこの誘導体の使用
CN113784970B (zh) * 2019-05-15 2022-11-29 南京明德新药研发有限公司 Erk抑制剂及其应用
KR20210015730A (ko) 2019-08-02 2021-02-10 웰마커바이오 주식회사 옥소-피리딘 융합고리 유도체 및 이를 포함하는 약학적 조성물
WO2022100586A1 (zh) * 2020-11-11 2022-05-19 南京明德新药研发有限公司 一种含氧杂环丁烷的螺环类化合物的晶型、制备方法及其应用
CN115413669B (zh) * 2022-06-14 2024-03-15 湖南大学 激酶抑制剂及其组合剂在提高植物青枯病抗性中的应用
WO2025067459A2 (en) 2023-09-29 2025-04-03 D3 Bio (Wuxi) Co., Ltd. Therapies for the treatment of cancer

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009847A1 (en) 1993-10-01 1995-04-13 Ciba-Geigy Ag Pyrimidineamine derivatives and processes for the preparation thereof
PT672042E (pt) 1993-10-01 2006-08-31 Novartis Ag Derivados de pirimidinoamina farmacologicamente activos e processos para a sua preparacao
US5543523A (en) 1994-11-15 1996-08-06 Regents Of The University Of Minnesota Method and intermediates for the synthesis of korupensamines
CZ9902016A3 (cs) 1996-12-05 1999-11-17 Amgen Inc. Substituované pyrimidinonové a pyridonové sloučeniny a způsoby jejich použití
US6602872B1 (en) * 1999-12-13 2003-08-05 Merck & Co., Inc. Substituted pyridazines having cytokine inhibitory activity
RU2277911C2 (ru) 2000-02-25 2006-06-20 Ф.Хоффманн-Ля Рош Аг Модуляторы аденозиновых рецепторов
HUP0300927A2 (hu) 2000-04-26 2003-07-28 Eisai Co., Ltd. Új pirimidinszármazékok és ezeket tartalmazó defekációt elősegítő gyógyszerkészítmények
ATE279390T1 (de) 2000-05-02 2004-10-15 Tietze Lutz F Prof Dr Neue prodrugs von 6-hydroxy-2,3-dihydro-1h- indolen, 5-hydroxy-1,2-dihydro-3h-pyrrolo 3,2- e)indolen und 5-hydroxy-1,2-dihydro-3h-benzo e)indolen sowie von 6-hydroxy-1,2,3,4-tetrahydro- benzo f)chinolin-derivaten für eine selektive krebstherapie
WO2002088079A2 (en) 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
WO2003030909A1 (en) 2001-09-25 2003-04-17 Bayer Pharmaceuticals Corporation 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
TWI330183B (enExample) * 2001-10-22 2010-09-11 Eisai R&D Man Co Ltd
US20050043315A1 (en) * 2002-01-02 2005-02-24 Hideo Tsutsumi Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
PT1490064E (pt) * 2002-02-14 2009-12-28 Pharmacia Corp Piridinonas substituídas como moduladores de p38 map-quinase
AU2003234628B2 (en) * 2002-05-21 2007-08-23 Amgen Inc. Substituted heterocyclic compounds and methods of use
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
WO2004007468A1 (en) 2002-07-15 2004-01-22 Merck & Co., Inc. Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
US20050014753A1 (en) 2003-04-04 2005-01-20 Irm Llc Novel compounds and compositions as protein kinase inhibitors
CL2004002050A1 (es) * 2003-08-13 2005-06-03 Pharmacia Corp Sa Organizada B Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
TW200533357A (en) 2004-01-08 2005-10-16 Millennium Pharm Inc 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
JP2007532669A (ja) 2004-04-13 2007-11-15 イカジェン インコーポレイテッド カリウムイオンチャネル調節剤としての多環式ピリミジン
US7429604B2 (en) * 2004-06-15 2008-09-30 Bristol Myers Squibb Company Six-membered heterocycles useful as serine protease inhibitors
WO2006021458A2 (en) 2004-08-27 2006-03-02 Gpc Biotech Ag Pyrimidine derivatives
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
GB0428514D0 (en) 2004-12-31 2005-02-09 Prosidion Ltd Compounds
CA2606288A1 (en) 2005-04-18 2006-10-26 Neurogen Corporation Subtituted heteroaryl cb1 antagonists
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7572809B2 (en) 2005-12-19 2009-08-11 Hoffmann-La Roche Inc. Isoquinoline aminopyrazole derivatives
KR20080103996A (ko) 2006-02-16 2008-11-28 쉐링 코포레이션 Erk 억제제로서 피롤리딘 유도체
WO2007125405A2 (en) 2006-05-01 2007-11-08 Pfizer Products Inc. Substituted 2-amino-fused heterocyclic compounds
DE102006035202A1 (de) 2006-07-29 2008-01-31 Lanxess Deutschland Gmbh Konservierungsmittel auf Basis von Carbonsäureanhydriden
ES2373587T3 (es) 2006-08-23 2012-02-06 Pfizer Products Inc. Compuestos de pirimidona como inhibidores de gsk-3.
WO2008039882A1 (en) 2006-09-30 2008-04-03 Sanofi-Aventis U.S. Llc A combination of niacin and a prostaglandin d2 receptor antagonist
JO2985B1 (ar) 2006-12-20 2016-09-05 Takeda Pharmaceuticals Co مثبطات كينازmapk/erk
EA200900799A1 (ru) 2006-12-22 2009-12-30 Новартис Аг Гетероарилгетероарильные соединения как ингибиторы cdk, предназначенные для лечения рака, воспаления и борьбы с вирусными инфекциями
EP2121674B1 (en) 2007-02-01 2010-05-12 Tibotec Pharmaceuticals Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
KR20100020454A (ko) 2007-06-08 2010-02-22 바이엘 크롭사이언스 소시에떼아노님 살진균제 헤테로사이클릴-피리미디닐-아미노 유도체
WO2009032861A1 (en) 2007-09-04 2009-03-12 The Scripps Research Institute Substituted pyrimidinyl-amines as protein kinase inhibitors
BRPI0817135A2 (pt) 2007-11-06 2014-10-07 Du Pont Composto, método de controle de doenças de plantas e composições fungicidas
MY152271A (en) 2008-02-21 2014-09-15 Merck Sharp & Dohme Novel compounds that are erk inhibitors
US20090246198A1 (en) 2008-03-31 2009-10-01 Takeda Pharmaceutical Company Limited Mapk/erk kinase inhibitors and methods of use thereof
PE20110136A1 (es) 2008-06-27 2011-03-17 Novartis Ag Compuestos organicos
NZ624345A (en) 2008-06-27 2016-07-29 Celgene Avilomics Res Inc 2,4-disubstituted pyrimidines useful as kinase inhibitors
PL2370413T3 (pl) * 2008-12-08 2016-01-29 Arena Pharm Inc Modulatory receptora prostacykliny (PGI2) użyteczne w leczeniu zaburzeń z nimi związanych
DE102009051799B4 (de) 2009-11-03 2021-07-01 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Bifunktionale Prodrugs und Drugs
DE102009060175A1 (de) 2009-12-23 2011-06-30 Merck Patent GmbH, 64293 Pyrrolo[2,3-d] pyrazin-7-yl-pyrimidin-Verbindungen
WO2012020786A1 (ja) * 2010-08-11 2012-02-16 日本新薬株式会社 医薬組成物
ES2543050T3 (es) 2011-02-28 2015-08-14 Array Biopharma, Inc. Inhibidores de serina/treonina quinasa
CN102250065B (zh) * 2011-05-20 2015-05-13 浙江海正药业股份有限公司 取代的三嗪苯脲衍生物及其用途
EP2739618B1 (en) 2011-08-04 2015-09-16 Array Biopharma, Inc. Quinazoline compounds as serine/threonine kinase inhibitors
AR090220A1 (es) * 2012-03-01 2014-10-29 Array Biopharma Inc Inhibidores de serina/treonina cinasa
MX369989B (es) 2012-08-27 2019-11-27 Array Biopharma Inc Inhibidores de serina/treonina cinasa para el tratamiento de enfermedades hiperproliferativas.
KR102244553B1 (ko) 2013-08-23 2021-04-23 가부시키가이샤 한도오따이 에네루기 켄큐쇼 용량 소자 및 반도체 장치
US9532987B2 (en) * 2013-09-05 2017-01-03 Genentech, Inc. Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases
WO2015103137A1 (en) * 2013-12-30 2015-07-09 Array Biopharma Inc. Serine/threonine kinase inhibitors
CA2934679C (en) * 2013-12-30 2023-02-28 Genentech, Inc. Serine/threonine kinase inhibitors
JP6723926B2 (ja) * 2014-04-09 2020-07-15 ジェネンテック, インコーポレイテッド 医薬の製造方法

Similar Documents

Publication Publication Date Title
JP2015508828A5 (enExample)
HRP20210482T1 (hr) Inhibitori serinske/treoninske kinaze
US20240360165A1 (en) Inhibitors of cyclin dependent kinase 7 (cdk7)
JP2017500364A5 (enExample)
KR102396710B1 (ko) 세린/트레오닌 키나제 저해제
AU2018201953A1 (en) Certain amino-pyridazines, compositions thereof, and methods of their use
JP2017502049A5 (enExample)
KR20160106627A (ko) 치료적 억제 화합물
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
KR102082331B1 (ko) Cot 조정제로서의 6-아미노-퀴놀린-3-카르보니트릴
JP2013527173A5 (enExample)
FI3356344T3 (fi) Mdm2-p53-vuorovaikutuksen isoindolinoniestäjiä, joilla on syövänvastaista aktiivisuutta
JP2016530299A5 (enExample)
EP2763672A1 (en) 1,3-substituted azetidine pde10 inhibitors
JP2014528446A5 (enExample)
JPWO2020165833A5 (enExample)
RU2019117958A (ru) Производные индола, полезные в качестве ингибиторов диацилглицерид-о-ацилтрансферазы 2
JPWO2022029573A5 (enExample)
KR101898364B1 (ko) 인돌린-2-온 및 1,3-다이하이드로-피롤로[3,2-c]피리딘-2-온 유도체
JPWO2021005034A5 (enExample)
JP2018111688A (ja) 医薬組成物
JPWO2017007008A1 (ja) 新規イミド誘導体およびその医薬としての用途
RU2025103751A (ru) Соединения на основе имидазопиридина, их получение и варианты их терапевтического применения
RU2022107496A (ru) Производные гетероциклического пиразола как ингибиторы рецепторной тирозикиназы типа III